WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale |
2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 4,787,123 6.200% |
-3,105,676 (-39.35%) |
Filing |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 7,892,799 10.260% |
-1,923,804 (-19.60%) |
Filing |
| 2024-02-08 10:17 am Purchase |
2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 9,816,603 13.010% |
2,385,696 (+32.11%) |
Filing |
| 2023-02-06 2:56 pm Sale |
2022-12-30 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 7,430,907 10.340% |
-724,140 (-8.88%) |
Filing |
| 2022-02-04 09:22 am Sale |
2021-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 8,155,047 11.540% |
-1,183,832 (-12.68%) |
Filing |
| 2021-02-04 09:57 am Purchase |
2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 9,338,879 13.690% |
2,519,420 (+36.94%) |
Filing |
| 2020-05-08 08:09 am Purchase |
2020-04-30 | 13G | PTC Therapeutics, Inc. PTCT |
WELLINGTON MANAGEMENT CO LLP | 6,819,459 10.850% |
5,767,802 (+548.45%) |
Filing |